Max Robotics — Global Service Robot Directory + US Certification

About

Matteo Pacini is a pioneering urologic surgeon and researcher whose work is reshaping the landscape of minimally invasive surgery, with a particular focus on robotic-assisted techniques for urologic cancers and benign prostatic hyperplasia. His major contributions center on advancing single-port (SP) robotic surgery, demonstrating its feasibility and advantages over traditional multiport approaches in complex patient populations. Pacini has shown that extraperitoneal single-port radical prostatectomy offers superior outcomes for frail patients, and that retroperitoneal single-port partial nephrectomy is safe even in those with "highly hostile abdomens." His research also explores novel access routes, such as supine lower anterior access, to minimize anesthesiologic impact. With over 100 citations across his most-cited works, including a highly influential 2024 review on recent advances in robotic urologic surgery, Pacini’s impact is clear. He has also developed and validated a novel comorbidity score specific to robotic prostate cancer patients, and created the first comprehensive atlas of supine single-port extraperitoneal access. His work on early continence recovery following radical prostatectomy, correlating MRI findings with urethral length, exemplifies his commitment to improving functional outcomes and quality of life for surgical patients.